616.234.5000
Through biomedical research and science education Van Andel Institute is committed to improving the health and enhancing the lives of current and future generations.

Learn More

Hot Papers

Read All

Is the enzyme ACMSD a novel therapeutic target in Parkinson’s disease? 
Keerthi Thirtamara-Rajamani, Peipei Li, Martha L. Escobar Galvis, Viviane Labrie, Patrik Brundin and Lena Brundin 
2017 | Journal of Parkinson’s Disease 

Assembly and architecture of the Wnt/β-catenin signalosome at the membrane 
Zachary J. DeBruine, H. Eric Xu and Karsten Melcher 
In press | British Journal of Pharmacology 

Therapeutic approaches to target alpha-synuclein pathology 
Patrik Brundin, Kuldip D. Dave and Jeffrey H. Kordower 
In press | Experimental Neurology 

SCIENTIFIC EVENTS

See All Events

Origins of Cancer

July 20, 2018

Epigenomics at VARI

August 6-11, 2018